Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rajesh Gontla

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Angewandte Chemie (International Ed. in English)|December 5, 2018
Enantioselective Formal C(sp<sup>3</sup> )-H Bond Activation in the Synthesis of Bioactive Spiropyrazolone DerivativesHouhua Li, Rajesh Gontla, Jana Flegel, et al.
Angewandte Chemie (International Ed. in English)|January 27, 2017
General Enantioselective C-H Activation with Efficiently Tunable Cyclopentadienyl LigandsZhi-Jun Jia, Christian Merten, Rajesh Gontla, et al.
RSC Medicinal Chemistry|December 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
RSC Medicinal Chemistry|February 23, 2024
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Angewandte Chemie (International Ed. in English)|June 26, 2015
Covalent-Allosteric Kinase InhibitorsJörn Weisner, Rajesh Gontla, Leandi van der Westhuizen, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Angewandte Chemie (International Ed. in English)|December 5, 2018
Enantioselective Formal C(sp<sup>3</sup> )-H Bond Activation in the Synthesis of Bioactive Spiropyrazolone DerivativesHouhua Li, Rajesh Gontla, Jana Flegel, et al.
Angewandte Chemie (International Ed. in English)|January 27, 2017
General Enantioselective C-H Activation with Efficiently Tunable Cyclopentadienyl LigandsZhi-Jun Jia, Christian Merten, Rajesh Gontla, et al.
RSC Medicinal Chemistry|December 22, 2022
A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
RSC Medicinal Chemistry|February 23, 2024
Correction: A high-throughput effector screen identifies a novel small molecule scaffold for inhibition of ten-eleven translocation dioxygenase 2Shubhendu Palei, Jörn Weisner, Melina Vogt, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Chemical Science|April 19, 2019
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase AktNiklas Uhlenbrock, Steven Smith, Jörn Weisner, et al.
Angewandte Chemie (International Ed. in English)|June 26, 2015
Covalent-Allosteric Kinase InhibitorsJörn Weisner, Rajesh Gontla, Leandi van der Westhuizen, et al.
Cancer Research|March 13, 2019
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in <i>KRAS</i>-Mutant Pancreatic and Colorectal CancerJörn Weisner, Ina Landel, Christoph Reintjes, et al.
Pageof 1